Dreampath is a high-quality business in a growing area of diagnostics, driven by increasing demand for better healthcare, more testing alongside new treatments, and rising rates of chronic disease as populations age,
2 / 10
“
Our premium, well-invested and differentiated pubs and bedrooms continue to deliver,
3 / 10
“
My ambition is to develop Parys Mountain into a flourishing mining operation,
4 / 10
“
The visible gold presence is supported by both photon and fire assay analysis, giving us further confidence in the high-grade nature of the mineralisation,
5 / 10
“
It is a key step in our dose expansion programme in ovarian and prostate cancers and builds on the exposure-response signal we have already observed with AO-252,
6 / 10
“
Our closed and forward order book stands at c.4,800 homes with a value of €1.8 billion, giving us confidence in our growth trajectory,
7 / 10
“
The strong performance has been driven by a continued uplift in contract wins, contract extensions, and revenue diversification,
8 / 10
“
We have entered FY27 with good momentum across the Group,
9 / 10
“
We have achieved significant growth across our core business and across all key markets and channels, while our ongoing commitment to investment in research and clinical studies continues to underpin demand for our products,
10 / 10
“
With this partnership, we have made it easier than ever for Canadian patients to upgrade their eyewear with our smart features, while also receiving precise vision correction and protection,
